BRPI0911019A2 - "pharmaceutical composition, pharmaceutical specialty, type II safflower oil micronized progesterone and use of type ii safflower micronized progesterone" - Google Patents

"pharmaceutical composition, pharmaceutical specialty, type II safflower oil micronized progesterone and use of type ii safflower micronized progesterone"

Info

Publication number: BRPI0911019A2
Authority: BR; Brazil
Prior art keywords: type; micronized progesterone; safflower; pharmaceutical; pharmaceutical composition
Prior art date: 2009-06-29

Application number

BRPI0911019A

Other languages

Portuguese (pt)

Inventor

Didier Terracol

Jennifer Gicquel

Roland Samoyeau

Original Assignee

Effik

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-29

Filing date

2009-12-09

Publication date

2016-07-19

2009-12-09 Application filed by Effik filed Critical Effik

2016-07-19 Publication of BRPI0911019A2 publication Critical patent/BRPI0911019A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Natural Medicines & Medicinal Plants (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Dispersion Chemistry (AREA)
Alternative & Traditional Medicine (AREA)
Reproductive Health (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0911019A 2009-06-29 2009-12-09 "pharmaceutical composition, pharmaceutical specialty, type II safflower oil micronized progesterone and use of type ii safflower micronized progesterone" BRPI0911019A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0954420A FR2947178B1 (en)	2009-06-29	2009-06-29	PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF
PCT/FR2009/052461 WO2011001039A1 (en)	2009-06-29	2009-12-09	Micronised progesterone pharmaceutical composition and uses thereof

Publications (1)

Publication Number	Publication Date
BRPI0911019A2 true BRPI0911019A2 (en)	2016-07-19

Family

ID=41664573

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0911019A BRPI0911019A2 (en)	2009-06-29	2009-12-09	"pharmaceutical composition, pharmaceutical specialty, type II safflower oil micronized progesterone and use of type ii safflower micronized progesterone"

Country Status (12)

Country	Link
US (1)	US20100330168A1 (en)
EP (1)	EP2269592B1 (en)
KR (1)	KR20120037363A (en)
BR (1)	BRPI0911019A2 (en)
CA (1)	CA2698513A1 (en)
CL (1)	CL2011000214A1 (en)
FR (1)	FR2947178B1 (en)
MA (1)	MA32548B1 (en)
MX (1)	MX2011002065A (en)
RU (1)	RU2011103136A (en)
WO (1)	WO2011001039A1 (en)
ZA (1)	ZA201100605B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2856520C (en)	2011-11-23	2021-04-06	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
AR100562A1 (en)	2014-05-22	2016-10-12	Therapeuticsmd Inc	PHARMACEUTICAL COMPOSITION OF ESTRADIOL AND PROGESTERONE FOR HORMONAL REPLACEMENT THERAPY
AU2015296609A1 (en)	2014-07-29	2016-12-22	Therapeuticsmd, Inc.	Transdermal cream
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
AU2017239645A1 (en)	2016-04-01	2018-10-18	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
FR3053252B1 (en) *	2016-06-29	2020-04-24	Laboratoires Carilene	PRODUCT, OR ACTIVE AGENT, OR COMPOSITION FOR THE CARE OF THE BREAST IN THE PRE-MONTHLY OR MENSTRUAL PERIOD OR FOR THE CARE OF THE SYMPTOMATOLOGY OF MASTODYNIA
EP3395332A1 (en)	2017-04-28	2018-10-31	Chemo Research, S.L.	Hormone softgel capsules and a process for the preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2408345A1 (en) *	1976-11-30	1979-06-08	Besins Jean Louis	NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION
US4963540A (en) *	1986-04-16	1990-10-16	Maxson Wayne S	Method for treatment of premenstrual syndrome
US4900734A (en) *	1987-08-27	1990-02-13	Maxson Wayne S	Novel pharmaceutical composition containing estradiol and progesterone for oral administration
WO1989002742A1 (en) *	1987-10-05	1989-04-06	Pharmagyn, Inc.	Tablet for use in the treatment of progesterone deficiency
US5093265A (en) *	1987-12-16	1992-03-03	Genesis Systems Corporation	Method for detecting of premenstrual syndrome
CA2059555A1 (en) *	1990-06-01	1991-12-02	Merrick L. Shively	Self-emulsifying glasses
US5912416A (en) *	1997-08-05	1999-06-15	California Oils Corporation	Safflower products with very high levels of unsaturated fatty acids
FR2832065B1 (en) *	2001-11-13	2004-11-05	Besins Int Belgique	PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD THEREOF AND USES THEREOF
MY142989A (en) *	2004-03-10	2011-02-14	Bayer Schering Pharma Ag	Stabilised supersaturated solids of lipophilic drugs
ATE543489T1 (en) *	2005-05-26	2012-02-15	Teva Womens Health Inc	ORAL DOSAGE FORMS CONTAINING PROGESTERONE AND METHODS OF USE AND MANUFACTURING THEREOF
EP2016833A1 (en) *	2007-07-17	2009-01-21	Cognis IP Management GmbH	Emulsion

2009
- 2009-06-29 FR FR0954420A patent/FR2947178B1/en not_active Expired - Fee Related
- 2009-12-09 BR BRPI0911019A patent/BRPI0911019A2/en not_active IP Right Cessation
- 2009-12-09 MX MX2011002065A patent/MX2011002065A/en unknown
- 2009-12-09 KR KR1020117018409A patent/KR20120037363A/en not_active Withdrawn
- 2009-12-09 RU RU2011103136/15A patent/RU2011103136A/en not_active Application Discontinuation
- 2009-12-09 WO PCT/FR2009/052461 patent/WO2011001039A1/en not_active Ceased
- 2009-12-09 EP EP09306200.8A patent/EP2269592B1/en active Active
2010
- 2010-04-06 CA CA2698513A patent/CA2698513A1/en not_active Abandoned
- 2010-06-28 US US12/824,489 patent/US20100330168A1/en not_active Abandoned
2011
- 2011-01-24 ZA ZA2011/00605A patent/ZA201100605B/en unknown
- 2011-01-31 CL CL2011000214A patent/CL2011000214A1/en unknown
- 2011-02-09 MA MA33597A patent/MA32548B1/en unknown

Also Published As

Publication number	Publication date
WO2011001039A1 (en)	2011-01-06
CA2698513A1 (en)	2010-12-29
ZA201100605B (en)	2012-04-25
US20100330168A1 (en)	2010-12-30
FR2947178B1 (en)	2012-07-06
EP2269592A1 (en)	2011-01-05
CL2011000214A1 (en)	2011-05-27
EP2269592B1 (en)	2013-08-07
KR20120037363A (en)	2012-04-19
FR2947178A1 (en)	2010-12-31
MX2011002065A (en)	2011-09-01
RU2011103136A (en)	2013-08-10
MA32548B1 (en)	2011-08-01

Publication	Publication Date	Title
BRPI0911019A2 (en)	2016-07-19	"pharmaceutical composition, pharmaceutical specialty, type II safflower oil micronized progesterone and use of type ii safflower micronized progesterone"
BRPI1011876A2 (en)	2015-09-22	"stable pharmaceutical composition and methods of use"
BRPI0912717A2 (en)	2014-12-23	PHARMACEUTICAL COMPOSITION, AND, USE OF 5-AZACYTIDINE
BR112012002331A2 (en)	2019-09-24	antiviral composition, pharmaceutical composition and use of effective amount of pharmaceutical composition
BRPI1011952A2 (en)	2016-04-26	"fuel compositions comprising isoprene derivatives"
SMT201600388B (en)	2017-03-08	LIGANDI OPSIN BINDERS, COMPOSITIONS AND METHODS OF USE
BRPI1009324A2 (en)	2015-11-24	and / or pharmaceutically acceptable compounds thereof, pharmaceutical composition and their uses
BR112012003842A2 (en)	2016-03-22	pharmaceutical composition, method of formulation and use thereof
SMT201500213B (en)	2015-10-30	Some triazolopirazine, their compositions and methods of use
BRPI1014854A2 (en)	2016-05-03	"polymer-agent conjugates, particles, compositions, and related methods of use"
BRPI0908021A2 (en)	2015-07-21	Compound, Pharmaceutical Composition, and, Uses of Compound or Pharmaceutical Composition
BRPI1009372A2 (en)	2016-05-31	compounds, pharmaceutical composition and their uses
BRPI0820899A2 (en)	2014-09-30	COSMETIC FORMULATION, AND, USE OF COMPOSITION
DK1984009T3 (en)	2013-01-28	Pharmaceutical compositions with improved stability
BR112012013148A2 (en)	2017-03-21	pharmaceutical formulation and use
ZA201007170B (en)	2012-01-25	Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
DK2432456T3 (en)	2022-04-04	FIXED PHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR THE PREPARATION
BRPI0921699A2 (en)	2016-02-16	antioxidant complex, cosmetic and pharmaceutical compositions containing said complex and use of this complex
CL2007002377A1 (en)	2008-04-04	COMPOUNDS DERIVED FROM QUINAZOLINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE AS ANTICANCERIGENO.
BRPI0821115A2 (en)	2015-06-16	Aminotriazole-derived compound, drug, pharmaceutical composition and use of compound
BRPI1013421A2 (en)	2016-04-05	topical parasticidal composition, and use of a
IL218490A (en)	2015-05-31	Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, compositions comprising the same and use thereof in the preparation of pharmaceutical compositions
EP2550954A4 (en)	2015-08-05	VASELINE-TYPE COMPOSITION AND COSMETIC PREPARATION
IL200153A (en)	2016-11-30	Ethanone derivatives, pharmaceutical compositions comprising them and use of same
BRPI0918206A2 (en)	2015-12-08	animoester derivatives and medicinal composition of these

Legal Events

Date	Code	Title	Description
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A E 6A ANUIDADES.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.